My watch list
my.bionity.com  
Login  

9 Current companies about the topic immunotherapies

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

CureVac AG

CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 18 years’ expertise in handling and optimizing this versatile molecule for medical purposes. The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human ...

more

image description
Abalos Therapeutics GmbH

Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Through viral replication within cancer cells, Abalos’ arenavirus-based drug ...

more

image description
Cherry Biolabs GmbH

Cherry biolabs was founded in 2019 as a Spin-off from the University Hospital of Würzburg with a focus on biotechnology and immunotherapy target validation. The essence of the technology is a T-cell engaging molecule that is split into two complementary fragments coined Hemibodies. Individual ...

more

image description
Bright Peak Therapeutics

Bright Peak is a privately held biotechnology company based in San Diego, CA and Basel, Switzerland developing innovative cytokine therapeutics that are uniquely engineered to precisely tune and control desired biological properties. Using its proprietary Enhanced Design and Combine (EDC) ...

more

image description
CatalYm GmbH

CatalYm is a biopharmaceutical company developing novel cancer immunotherapies targeting Growth-and-Differentiation Factor 15 (GDF-15). Apart from its established role in cachexia, GDF-15 has been associated with immunosuppression in tissues and tumors and a rapidly growing body of literature ...

more

image description
iTeos Therapeutics SA

iTeos Therapeutics is a privately-held, biopharmaceutical company dedicated to extending and improving the lives of cancer patients by designing and developing next generation immunotherapies. Based in Gosselies, Belgium and in Cambridge, MA, iTeos Therapeutics was founded out of the Ludwig ...

more

image description
NextCure, Inc.

NextCure, launched in 2015, is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy ...

more

image description
Triumvira Immunologics, Inc.

Triumvira Immunologics, Inc. (“Triumvira”) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the vision of developing novel T cell therapies that are safer and more efficacious than current cancer treatments, including ...

more

image description
DiosCURE Therapeutics SE

DiosCURE is advancing next-generation best-in-class immunotherapeutics to prevent and treat SARS-CoV-2 in order to combat the ongoing coronavirus pandemic. Due to their small size, our drug candidates can attach to unique surface structures of the SARS-CoV-2 spike protein. This passive ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE